Cite
HARVARD Citation
Buntinx, E. et al. (2023). Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naïve and exposed individuals in a phase 2/3, double-blind, randomized study. Vaccine. 41 (11), pp. 1875-1884. [Online].